The Annexure

News to 9 October 2026 ·

Desk›Chemicals› Mahamaya Lifesciences Ltd

Mahamaya Lifesciences Ltd

BSE 544611 · NSE MAHALIFE · ISIN INE0U9D01019 · Group M · Active

Commodities › Chemicals › Fertilizers & Agrochemicals › Pesticides & Agrochemicals

₹181.75

-0.68%

BSE close, 28 August 2026

Market cap

₹425.39 cr

2.3 cr shares · Micro cap

Free float

₹112.30 cr

as published

P/E · P/B

25.5× · —

EPS ₹7.14 · BV —

FY25-26 rev / PAT

328.87 / 16.72

₹ cr, as filed

Filings, window

16

6 selected · 38%

Regime

Reg 30

Sch. III Part A

Price 52-week, BSE

52-WK LOW ₹111.00 52-WK HIGH ₹205.05 ₹181.75 75% of range
Against 52-week high-11.4%
Against 52-week low+63.7%
Day change-0.68%
Size bandMicro cap
Index membershipNone

Valuation as published by BSE

Earnings per share₹7.14
Price / earnings25.46×
Price / book—
Book value — derived, price ÷ P/B—
Return on equity—
Operating margin—
Net margin—

Results ₹ crore, as filed

RevenueNet profit one scale across all three periods, ₹ crore

PeriodRevenue ₹cr Net profit ₹cr EPS ₹OPM NPM
Mar-26 · Q 165.81 8.20 3.74 10.82% 4.94%
Sep-25 · Q 163.06 8.53 4.80 10.13% 5.23%
FY25-26 328.87 16.72 8.43 10.48% 5.08%

Quarter on quarter

Revenue, quarter on quarter
+1.7%
Net profit, quarter on quarter
-3.9%
Operating margin, quarter on quarter
+69 bps

Disclosure profile 16 filings in the window

0 median 16.0 sector max 62 16 55th percentile of 300 Chemicals filers
Shaded is the middle half of the sector, 12 to 20 filings. Measured against the 300 Chemicals companies that filed at all in this window — companies with no filings are excluded, so this is a percentile against filers rather than against the sector.

Disclosure regime

LODR Reg 30

Read with Schedule III Part A. An equity filer in BSE Group M, so the Regulation 30 disclosure framework and the Schedule III event list both apply.

Sources Price, day change, 52-week range — bse.quote, bse.quoteWeeklyHL, 28 August 2026 close. Market cap and free float — bse.getScripTradingStats. P/E, P/B, EPS, ROE, margins — bse.equityMetaInfo. Quarterly and annual results — bse.resultsSnapshot, standalone, as filed. Four-tier classification — data/reference/companies.csv. Filing counts and tags — the build aggregate for this window. Notes Share count is derived as market cap ÷ price. Figures move between captures and between vendors, and the two are not an error in either: companies.csv carries the market cap from an earlier sweep than the snapshot above. EPS appears twice with different meanings — the figure beside P/E is the trailing one from equityMetaInfo, while the EPS in the results table is the per-period figure as filed.

Filing rhythm · 93 trading days

16 filings · 6 selected · busiest 2026-08-25 and 2026-09-07

Filing rhythm · the twelve most recent

2026-08-252026-10-09

SelectedProcedural

Filings

16 in the window · 2 earlier on record

  1. 9 October 2026 ·

    General

    Publication Of Executive Interview In Agropages Magazine (2026 India Focus Issue)

    Publication of Executive Interview in AgroPages Magazine (2026 India Focus Issue)

    Company Update / General View filing →

  2. 8 October 2026 ·

    Compliance Certificate

    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018

    Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →

  3. 30 September 2026 ·

    Change in Management

    Change in Management

    Appointment of Dr. Bhagirath Choudhary as Independent Director, Re-appointment of Dr. Charudatta Digambar Mayee as Independent Director, Re-appointment of Mr. Gopal Krishna Raju as Independent ....

    Company Update / Change in Management View filing →

  4. 30 September 2026 ·

    AGM / EGM

    Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    Mahamaya Lifesciences Limited has informed the exchange regarding the voting results and scrutinizer report of the 24th Annual General Meeting held on September 29, 2026

    AGM/EGM / AGM View filing →

  5. 29 September 2026 ·

    AGM / EGM

    Shareholder Meeting / Postal Ballot-Outcome of AGM

    Mahamaya Lifesciences Limited has informed the exchange regarding proceedings of 24th Annual General Meeting held on September 29, 2026

    AGM/EGM / AGM View filing →

  6. 28 September 2026 ·

    Trading Window

    Closure of Trading Window

    Intimation of Closure of Trading Window

    Insider Trading / SAST / Closure of Trading Window View filing →

  7. 8 September 2026 ·

    Newspaper Publication

    Newspaper Publication

    Newspaper Advertisement of Completion of Dispatch of the Notice of 24th Annual General Meeting

    Company Update / Newspaper Publication View filing →

  8. 7 September 2026 ·

    Annual Report

    Reg. 34 (1) Annual Report.

    Annual Report for the Financial Year 2025-26

    Others / Reg. 34 (1) Annual Report View filing →

  9. 7 September 2026 ·

    AGM / EGM

    Notice Of 24Th Annual General Meeting Of The Company

    Notice of 24th Annual General Meeting scheduled to be held on Tuesday, September 29, 2026

    AGM/EGM / AGM View filing →

  10. 7 September 2026 ·

    Newspaper Publication

    Newspaper Publication

    Newspaper Advertisement regarding pre-dispatch intimation of 24th AGM of the Company

    Company Update / Newspaper Publication View filing →

  11. 25 August 2026 ·

    Change in Directorate

    Change in Directorate

    Appointment of Mr. Bhagirath Choudhary as Additional Independent Director, Re-appointment of Dr. Gopal Krishna Raju as Independent Director, Re-appointment of Dr. Charudatta Digambar Mayee ....

    Company Update / Change in Directorate View filing →

  12. 25 August 2026 ·

    Change in Management

    Change in Management

    Relinquishment from the post of Mr. Prashant Krishnamurthy as Chief Financial Officer upon the closure of business hours on October 31, 2026 and Appointment of Mr. Amarendra Mohaptra as ....

    Company Update / Change in Management View filing →

  13. 25 August 2026 ·

    KMP

    Appointment of Company Secretary and Compliance Officer

    Appointment of Mr. Kush Mishra as Company Secretary and Compliance Officer

    Company Update / Appointment of Company Secretary / Compliance Officer View filing →

  14. 7 August 2026 ·

    Investor Presentation

    Investor Presentation

    Investor Presentation to be shared during Investor Meet scheduled to be held on 07th August, 2026

    Company Update / Investor Presentation View filing →

  15. 4 August 2026 ·

    Analyst / Investor Meet

    Analyst / Investor Meet - Intimation

    Intimation of Schedule of Analyst(s) /Investor(s) meeting

    Company Update / Analyst / Investor Meet View filing →

  16. 30 July 2026 ·

    KMP

    Resignation of Company Secretary / Compliance Officer

    Resignation of Company Secretary and Compliance Officer

    Company Update / Resignation of Company Secretary / Compliance Officer View filing →

RSS feed for Mahamaya Lifesciences Ltd · the 50 most recent filings